Esteemed Heart Surgeon Blows The Lid Off The Big Pharma

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
275
Esteemed Heart Surgeon Blows The Lid Off The Big Pharma Statin Drug Scam

https://www.naturalblaze.com/2018/12/esteemed...-scam.html

physician’s word is often taken very seriously and with little skepticism. An opinion from one or two doctors, when made in a professional office or hospital, can persuade a worried patient to take drugs with complex side-effects, or even undergo traumatic treatments such as radiation and chemotherapy. Yet, when the same doctors, with years of experience and thousands of satisfied customers, give an opinion that questions a therapy established by mainstream medicine, the mainstream media calls them irresponsible, or quacks, or even criminals.

Many doctors are highly admirable people, but they are still human beings. They all make mistakes, they all learn from them, but the really good ones are willing to admit to them.

Which brings us to Dr. Dwight Lundell. He’s an experienced heart surgeon and retired Chief of Staff and Chief of Surgery at Banner Heart Hospital in Mesa, Arizona. Not so long ago, Dr. Lundell made the following statement of confession:

We physicians with all our training, knowledge and authority often acquire a rather large ego that tends to make it difficult to admit we are wrong. So, here it is. I freely admit to being wrong. As a heart surgeon with 25 years experience, having performed over 5,000 open-heart surgeries, today is my day to right the wrong with medical and scientific fact.

I trained for many years with other prominent physicians labeled “opinion makers.” Bombarded with scientific literature, continually attending education seminars, we opinion makers insisted heart disease resulted from the simple fact of elevated blood cholesterol. The only accepted therapy was prescribing medications to lower cholesterol and a diet that severely restricted fat intake. The latter of course we insisted would lower cholesterol and heart disease. Deviations from these recommendations were considered heresy and could quite possibly result in malpractice. It Is Not Working!

These recommendations are no longer scientifically or morally defensible.

Not surprisingly, Lundell’s statement regarding the medical establishment’s approach to treating heart disease caused a ripple in the medical industry. It challenged the validity of statins – commonly known as cholesterol-lowering medications – such as Lipitor, Crestor, Zocor, and others.

The reason Lundell’s statement created such a buzz is because statins are big business. In the United States alone, about 25% of the population takes statin medications. They cost from as little as $53 per month to more than $600. Pfizer’s Lipitor went on sale in 1997 and its lifetime sales have surpassed $125 billion. AstraZeneca’s Crestor was the top-selling statin in 2013, generating $5.2 billion in revenue that year alone. The statin industry is estimated at around $30 billion in sales per year. Nevertheless, in the United States, more die each year of heart disease than ever before.

Lundell went on to say:

The discovery a few years ago that inflammation in the artery wall is the real cause of heart disease is slowly leading to a paradigm shift in how heart disease and other chronic ailments will be treated. The long-established dietary recommendations have created epidemics of obesity and diabetes, the consequences of which dwarf any historical plague in terms of mortality, human suffering and dire economic consequences.

I have peered inside thousands upon thousands of arteries. A diseased artery looks as if someone took a brush and scrubbed repeatedly against its wall. Several times a day, every day, the foods we eat create small injuries compounding into more injuries, causing the body to respond continuously and appropriately with inflammation. While we savor the tantalizing taste of a sweet roll, our bodies respond alarmingly as if a foreign invader arrived declaring war. Foods loaded with sugars and simple carbohydrates, or processed with omega-6 oils for long shelf life have been the mainstay of the American diet for six decades. These foods have been slowly poisoning everyone.

Simply, it is the foods that are baked or soaked in soybean oil and ones that are processed for long shelf-life that are creating an extreme imbalance of omega-6 and omega-3 fats in people’s bodies. Lundell estimates the ratio of imbalance “ranges from 15:1 to as high as 30:1 in favor of omega-6.” A healthy ratio is closer to 3:1.

But what makes Lundell’s statements controversial is that cholesterol does not cause heart disease…which makes statin drugs superfluous. And he suggests a treatment to heart disease that doesn’t make Big Pharma any money:

Simply stated, without inflammation being present in the body, there is no way that cholesterol would accumulate in the wall of the blood vessel and cause heart disease and strokes. Without inflammation, cholesterol would move freely throughout the body as nature intended. It is inflammation that causes cholesterol to become trapped.

Since we now know that cholesterol is not the cause of heart disease, the concern about saturated fat is even more absurd today. The cholesterol theory led to the no-fat, low-fat recommendations that in turn created the very foods now causing an epidemic of inflammation. Mainstream medicine made a terrible mistake when it advised people to avoid saturated fat in favor of foods high in omega-6 fats. We now have an epidemic of arterial inflammation leading to heart disease and other silent killers. What you can do is choose whole foods your grandmother served and not those your mom turned to as grocery store aisles filled with manufactured foods. By eliminating inflammatory foods and adding essential nutrients from fresh unprocessed food, you will reverse years of damage in your arteries and throughout your body from consuming the typical American diet.

It probably comes as no surprise that Lundell has been portrayed as a quack by the mainstream medical establishment. The main argument to back up his “quackery” was that his medical license was revoked in 2008…although the man was already retired and had no plans to return to the surgery room. He was not called a quack when he was performing surgeries, but once he took his 25 years of practice and discerned what he believes is the cause of heart disease, it was then that he was attacked by his peers. Which brings up the question if Lundell came onto the American Medical Association’s radar as he was working on and promoting his book, The Cure for Heart Disease, which was published in 2007.

Millions of dollars are made from heart disease treatment and statin medications. This established industry does not want anyone to interfere. Lundell said it himself, “Deviations from these recommendations were considered heresy and could quite possibly result in malpractice.” And it sure is easier to discredit a retired heart surgeon and chief of surgery with 25 years of experience if you revoke his license.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nailah Thorbourne's Vlair Shapewear: Fashion Freedom

Updated Category News Views 3

Fashion with a Punch: Nailah Thorbourne's New Venture You'd think from the way the fashion industry's been humming along that someone would've cracked the code on shapewear a long time ago, right? But alas, it takes Nailah Thorbourne to step out of Brick & Lace's spotlight and into this shapely market with Vlair Shapewear. Apparently, what most overlooked in comfort, she...

Continue Reading
HiBy Unveils Cyberpunk 2077 Gaming Audio Line

Updated Category News Views 4

HiBy Hits the Gaming Scene with Cyberpunk Flair It's a wild world when audio tech and gaming collide outside of the usual suspects. HiBy's latest move is a bold pivot into the gaming universe, launching an audacious collaboration with, of all things, the cybernetic chaos of Cyberpunk 2077. You can almost feel the underlying scrappiness of Night City embedded into a couple...

Continue Reading
Newsom's Veto Sparks Controversy Over Wildfire Insurance

Updated Category News Views 4

A Flames of Controversy Light Up California's Insurance Arena Some days, you look at the headlines and just think, "What the heck is going on here?" When Governor Gavin Newsom struck down two critical bills designed to help wildfire survivors, it wasn't just bureaucratic arm-wrestling. It landed like a gut punch to a state already licking its wounds from raging wildfires....

Continue Reading
Colson Group Expands with Algood Acquisition

Updated Category News Views 11

A Big Move in Mobility Solutions Put on your seatbelts, because Colson Group is steering into a new lane with its acquisition of Algood Caster Innovations. This ain't just any pickup—it's a smart move that could ramp up their North American manufacturing clout and mobility solutions. You know, mergers like these don't come around by accident. Colson sees something...

Continue Reading
Gray's Rise in ENR Rankings Highlights Sector Dominance

Updated Category News Views 6

Gray's Outstanding Reputation in the Construction Arena Nothing says “we're on top of our game” like snatching top slots in industry rankings, and that's precisely what Gray, the construction and engineering heavyweight, has managed to do. This firm recently secured impressive spots across ten different categories in the prestigious Engineering News-Record (ENR) Top...

Continue Reading
RiskScout Rides High on Funding, Tackles Financial Crime

Updated Category News Views 4

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...

Continue Reading
Appy Pie Secures Patent for AI Driven App Building

Updated Category News Views 3

A New Dawn in App Creation You ever think about a world where creating an app is as straightforward as chatting with an old buddy? Well, that future's knocking at the door, courtesy of Appy Pie. They're ruffling feathers with a shiny new U.S. patent promising just that—apps whipped into shape by a bit of chitchat with their AI-powered platform. It's got folks scratching...

Continue Reading
NUS Unveils eLuminator: A Leap for Robotics & Healthcare

Updated Category News Views 3

Game-Changing Electronic Skin From NUS It's not every day you come across tech that could shake up multiple industries, but that's just what the National University of Singapore has cooked up with their latest brainchild—the eLuminator. This ain't your everyday wearable tech. We're talking a skin-like device that can both detect and show touch in real-time, no fiddly...

Continue Reading
Primrose Schools App: A Bold Step for Digital Literacy

Updated Category News Views 5

Primrose Schools Delivers a New Era in Child Education Sitting at a crossroads between the tactile charm of hands-on learning and the inevitable march of digital literacy, Primrose Schools has unveiled something that might just rock the boat in early education: their new Balanced Learning® App. This move by Primrose comes at a crucial time when many parents are...

Continue Reading
Janitorial Wages Soar 26.7% Amid High Annual Openings

Updated Category News Views 3

Janitorial Sector Faces Wage Surge and Employment Shifts Look, if you thought the world of janitorial work was all brooms and mops without a paycheck edge, think again. From 2020 to 2025, wages for janitors and building cleaners didn't just tip-toe up the ladder—they practically sprinted, climbing 26.7%. BLS data laid this one out, with hourly pay shooting from $13.98...

Continue Reading

Top 5 Most Recently Viewed Articles

Forecasting Earnings for Silvercrest Asset Management Group

Updated Category News Views 118

Anticipating Silvercrest Asset Management Group's Earnings Silvercrest Asset Management Group (NASDAQ: SAMG) is poised to announce its quarterly earnings soon. Investors are eager to see how the company performs in this upcoming release. Market analysts expect the earnings per share (EPS) to be around $0.30, indicating a steady outlook among stakeholders. Expectations...

Continue Reading
Discovering New Opportunities in Shares of Conagra and EQT

Updated Category News Views 194

Investment Insights from CNBC's Halftime Report On CNBC's “Halftime Report Final Trades,” Jenny Van Leeuwen Harrington, CEO of Gilman Hill Asset Management, shared her insights on Conagra Brands, Inc. (NYSE: CAG). She noted that the company trades at an attractive price-to-earnings ratio of just 10 times earnings and offers a solid dividend yield of 7.5%. CAG's...

Continue Reading
CPS Achieves Significant Milestone with $418.33 Million Deal

Updated Category News Views 144

Consumer Portfolio Services Announces Major Securitization Consumer Portfolio Services, Inc. (NASDAQ: CPSS) recently celebrated a significant achievement as it closed its third term securitization of the year. This milestone transaction marked the company’s 56th senior subordinate securitization since 2011, maintaining its exemplary record with 39 consecutive...

Continue Reading
Chicago Atlantic BDC Expands Cannabis Lending with New Ticker

Updated Category News Views 174

Chicago Atlantic BDC Takes Major Step in Cannabis Lending Chicago Atlantic, a prominent investment manager, recently acquired Silver Spike Investment Corp., marking a significant evolution in the cannabis lending sector. This acquisition is particularly noteworthy as Silver Spike was the sole SEC-approved business development company (BDC) focused specifically on...

Continue Reading
Understanding Synthetic Urine: Temperature Issues in Specimen Testing

Updated Category News Views 117

Understanding Temperature's Impact on Urine Sample Validity Quick Fix Synthetic emphasizes to laboratory professionals and researchers that temperature remains the primary cause for urine sample rejection. Current industry data indicates a troubling increase in the rate of invalid samples. Significance of Temperature in Sample Collection Laboratory standards require that...

Continue Reading